- 1The Reproductive Medicine Center, Peking University Shenzhen Hospital, Shenzhen, Guangdong, China
- 2Reproductive Medical Center, Peking University Third Hospital, Beijing, China
- 3Fertility Preservation Lab, Reproductive Medicine Center, Guangdong Second Provincial General Hospital, Guangzhou, China
- 4Department of Clinical Research, Yikon Genomics Company, Ltd., Suzhou, China
A Correction on
Effectiveness of non-invasive chromosomal screening for normal karyotype and chromosomal rearrangements
by Sun B-l, Wang Y, Sixi-Wen, Zhou L, Zhang C-H, Wu Z-X, Qiao J, Sun Q-Y, Yao Y-X, Wang J, Yi Z-Y and Qian W-P (2023). Front. Genet. 14:1036467. doi: 10.3389/fgene.2023.1036467
The funder “Key projects of basic research plan of Shenzhen Science and technology innovation Commission (JCYJ20200109140623124)” was erroneously omitted. The funder has now been added at the beginning of the Funding statement, which now reads as follows:
This study was supported by the Key projects of basic research plan of Shenzhen Science and technology innovation Commission (JCYJ20200109140623124), the Exploration of New Method of Non-invasive Fertility Evaluation and Establishment of National Standard (Grant No. (2018YFC1002104)); The National Natural Science Foundation of China (Grant No. (31530049)); The Research Team of Female Reproductive Health and Fertility Preservation (Grant No. (SZSM201612065)); The Natural Science Foundation of Guangdong Province (Grant No. (2018A030310673)); The Project for Medical Discipline Advancement of Health and Family Planning commission of Shenzhen Municipality (Grant No. (SZXJ2017003)); The National Natural Science Foundation of China (Grant No. (82001541)); and the National Natural Science Foundation of China (Grant No (8200062044)).
The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: non-invasive chromosomal screening, assisted reproductive technology, chromosomal ploidy, next-generation sequencing, blastocyst culture medium, clinical outcomes
Citation: Sun B-L, Wang Y, Wen S, Zhou L, Zhang C-H, Wu Z-X, Qiao J, Sun Q-Y, Yao Y-X, Wang J, Yi Z-Y and Qian W-P (2025) Correction: Effectiveness of non-invasive chromosomal screening for normal karyotype and chromosomal rearrangements. Front. Genet. 16:1711906. doi: 10.3389/fgene.2025.1711906
Received: 24 September 2025; Accepted: 29 September 2025;
Published: 27 October 2025.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2025 Sun, Wang, Wen, Zhou, Zhang, Wu, Qiao, Sun, Yao, Wang, Yi and Qian. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Zi-Yun Yi, c2Nzbnl6eUAxMjYuY29t; Wei-Ping Qian, cWlhbndlaXBpbmdzekAxMjYuY29t
†These authors have contributed equally to this work
Yong Wang1†